ANNIKA SILFVAST-KAISER to Humans
This is a "connection" page, showing publications ANNIKA SILFVAST-KAISER has written about Humans.
Connection Strength
0.083
-
How can we manage the safety concerns associated with the increase in biologics for psoriasis? Expert Opin Drug Saf. 2020 Apr; 19(4):361-364.
Score: 0.017
-
Diet in hidradenitis suppurativa: a review of published and lay literature. Int J Dermatol. 2019 Nov; 58(11):1225-1230.
Score: 0.016
-
Anti-IL17 therapies for psoriasis. Expert Opin Biol Ther. 2019 01; 19(1):45-54.
Score: 0.016
-
Hemorrhagic bullous IgA vasculitis in pediatric skin of color: an mpox mimicker. Int J Dermatol. 2024 Apr; 63(4):541-542.
Score: 0.006
-
MOdified DEroofing With Scar Excision (MODES Procedure) for the Surgical Treatment of Hidradenitis Suppurativa. J Cutan Med Surg. 2023 Jan-Feb; 27(1):69-71.
Score: 0.005
-
Cryptococcal meningitis associated with interleukin-17 inhibitor use for psoriasis. Dermatol Ther. 2022 08; 35(8):e15609.
Score: 0.005
-
BAPoma presenting as an incidental scalp papule: case report, literature review, and screening recommendations for BAP1 tumor predisposition syndrome. J Dermatolog Treat. 2022 Jun; 33(4):1855-1860.
Score: 0.005
-
Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: Patient adherence, satisfaction, and preferences. Dermatol Ther. 2021 01; 34(1):e14486.
Score: 0.005
-
An unusual presentation of cutaneous sarcoidosis. Dermatol Ther. 2020 07; 33(4):e13546.
Score: 0.004
-
Adams-Oliver Syndrome Type 2 in Association with Compound Heterozygous DOCK6 Mutations. Pediatr Dermatol. 2017 Sep; 34(5):e249-e253.
Score: 0.004